A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...

A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...

Add Yahoo as a preferred source to see more of our stories on Google. A 3D illustration of human lungs. The Food and Drug Administration on Tuesday approved a new drug for idiopathic pulmonary ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school. But for many, the virus leaves behind a lasting impact—especially in ...

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

COVID has always been more than a bad bout of flu. As the pandemic’s acute waves recede, a different crisis is coming into focus: a generation of survivors living with damaged lungs, disrupted ...

Study found which abnormal cells talk to each other in harmful ways and perpetuate lung damage Scientists are already exploring therapeutic strategies based on this study’s discoveries Treatments also ...

A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...

In a study published this week in JCI Insight, Dr. Ankit Bharat, director of the Northwestern Medicine Canning Thoracic Institute, laid out how abnormal cells emerge and work to cause lung damage and ...

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical ...